Availability of internationally controlled pharmaceutical opioids for medical use has stabilized in recent years.Availability of pharmaceutical opioids for medical use more than doubled between 1998 and 2024 – driven by a strong increase until 2013, followed by a decline and partial recovery in…
There remains a large discrepancy between the Global North and the Global South in the availability of internationally controlled pharmaceutical opioids for medical use - even though the gap is declining.Between 2015 and 2024, the per capita availability of pharmaceutical opioids for medical use in…
Cultivation of cannabis continues in virtually every country worldwide, but certain dynamics may be discerned at global level.Trends reported on cannabis cultivation, as reported by Member States, suggest a prevalent increasing trend as of 2020, followed by a slowing down and apparent decline…
Cannabis herb seizures stabilized at high levels in 2024, with trafficking largely being intra-regional. But some new inter-regional flows, notably from North America, have emerged in recent years.Cannabis herb trafficking is global, with seizures suggesting a concentration in Africa and the…
The use of specific cultivation practices, in parallel with a shift toward indoor cannabis cultivation, has likely contributed to increasing cannabis herb potency, notably in industrialized countries. These developments, alongside an ever-broader variety of cannabis products, are likely being…
Cannabis resin seizures indicate a contracting market, as cannabis herb (with high levels of THC) is increasingly replacing cannabis resin.Cannabis resin seizures showed an upward trend until 2020 but have since fallen sharply across all regions – by more than 50 per cent globally – pointing to a…
Cannabis seizures stabilized at high levels in 2024.Global seizures of cannabis herb and resin stabilized at high levels in 2024, following increases over the 2019-2023 period. However, whether the higher seizures, and their possible impact on supply, may be linked to the reported decline in the…
Heroin and morphine seizures remain concentrated in Asia.In line with the concentration of opium production in Asia, almost two thirds (64 per cent) of global heroin and morphine seizures occurred in Asia in 2024, notably in South-Western Asia and, to a lesser extent, in East and South-East Asia.In…
Seizures of key pharmaceutical opioids show distinct regional patterns by substance.While fentanyl seizures remain overwhelmingly concentrated in North America (> 99 per cent), other pharmaceutical opioids dominate seizures in different regions: codeine in West and Central Africa and South Asia…
Global illicit opium production remained more than 70 per cent below 2022 levels in 2025Global illicit opium production remained at lower levels in 2025 at 2,100 tons, more than 70 per cent below 2022 (mainly due to Afghanistan’s opium ban) and almost 80 per cent below its 2017 peak.A doubling of…
Cannabis use remains widespread globally, with steady long-term growth.Prevalence of past-year cannabis use is highest in North America, Australia and New Zealand, and West and Central Africa, while North America and South Asia have the highest number of people who use cannabis.Cannabis use has…
Seven substances dominate the global availability of opioids under international control for medical consumption.Expressed in S-DDDs (defined daily doses for statistical purposes), methadone, followed by hydrocodone, fentanyl, buprenorphine, oxycodone, codeine (including preparations) and morphine…
